Top Markets
#1 QuantixAI QuantixAI +31.15%
#2 Prom Prom +29.37%
#3 MowCat MowCat +27.03%
#4 Tutorial Tutorial +25.45%
#5 Pons Pons +23.80%
#6 UnifAI Network UnifAI Network +23.49%
#7 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +19.80%
#8 Derive Derive +19.11%
#9 Versatize Coin Versatize Coin +16.66%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +10.19%
Coin of the day
QuantixAI QuantixAI
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Fangzhou Inc. Fangzhou Inc.

Fangzhou Inc.

6086
Rangering i aksjer #20931
Headquartered in Guangzhou, China, Fangzhou Inc. delivers comprehensive online... Headquartered in Guangzhou, China, Fangzhou Inc. delivers comprehensive online chronic disease management services throughout the nation. The company leverages its dedicated digital platform to assist individuals grappling with long-term health issues like hypertension, cardiovascular, and respiratory conditions. Its mobile application facilitates a suite of "H2H" services, comprising virtual medical consultations, e-prescribing, and prescription renewal options. Furthermore, Fangzhou provides healthcare products through an online retail pharmacy and manages its own network of hospitals and brick-and-mortar pharmacies. The company was established in 2015.
Aksjekurs
$0.08571057
Markedsverdi
$118.75M
Endring (1 dag)
0.00%
Endring (1 år)
-82.69%
Land
CN
Handel Fangzhou Inc. (6086)

Kategori

Healthcare
Inntekter for Fangzhou Inc. (6086)
Inntekter i 2026 TTM: 0
Ifølge Fangzhou Inc. sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Fangzhou Inc. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
$33.59B -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
$25.20B -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
$8.70B -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
$21.39B -
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
$5.95B -
US